science

Gilead Sciences Announced Licensing of Portfolio of HIV Antibodies

Gilead Sciences Announced Licensing of Portfolio of HIV Antibodies
3246 | 0

Gilead Sciences, Inc. (NASDAQ: GILD) announced Thursday that it has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074. These inve..

Illumina Terminates $1.2 Billion Acquisition of Pacific Biosciences

 Illumina Terminates $1.2 Billion Acquisition of Pacific Biosciences
2398 | 0
 More Buzz

IFF to Merge with DuPont’s Nutrition and Biosciences Business

 IFF to Merge with DuPont’s Nutrition and Biosciences Business
1787 | 0
 More Buzz

Daily Market Movers for November 12th, 2019

 Daily Market Movers for November 12th, 2019
1838 | 0
 More Buzz

Daily Market Movers for November 5th, 2019

 Daily Market Movers for November 5th, 2019
1819 | 0
 More Buzz

Daily Market Movers October 17th, 2019

 Daily Market Movers October 17th, 2019
3729 | 0
 More Buzz

Boxlight Acquires STEM Education Solutions Company

 Boxlight Acquires STEM Education Solutions Company
2287 | 0
 More Buzz

@Newsletter

Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Trending Financialinsiders News

No articles found.

All rights reserved.

No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).